Status:
UNKNOWN
Gynecological Symptoms and Health-related Quality of Life in Egyptian Women With SLE
Lead Sponsor:
Fayoum University
Conditions:
SLE
Menstrual Irregularity
Eligibility:
FEMALE
15-55 years
Brief Summary
The purpose of our study was to Recognize gynecological symptoms and health-related quality of life in Egyptian women with systemic lupus erythematosus and evaluate the impact of duration of remission...
Detailed Description
Despite significant advances in recent decades, systemic lupus erythematosus (SLE) is still burdened by irreversible organ damage and a notable impact on health-related quality of life (HRQoL). Improv...
Eligibility Criteria
Inclusion
- Patients fulfilling the American College of Rheumatology (ACR) 1982 revised criteria for SLE,
- age between 15 and 55 years
- and consented to the interview.
Exclusion
- Patients with active malignancy
- and end-stage lupus nephritis
- Patients who had been treated with Belimumab in the last 7 years, due to the reported effects of Belimumab on HRQoL.
Key Trial Info
Start Date :
January 15 2022
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
August 1 2023
Estimated Enrollment :
70 Patients enrolled
Trial Details
Trial ID
NCT05230316
Start Date
January 15 2022
End Date
August 1 2023
Last Update
May 1 2023
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Fayoum university faculity of medicine
Al Fayyum, Fayoum University Zone, Egypt, 63514
2
Fayoum university
Al Fayyum, Egypt, 63514